I ask you as a representative of my community, as a proud American, as a scientist, and as a patient, to join me in asking Mr. O'Day what justification do you have for charging $2,000 a month for Truvada as PrEP when the American people funded the innovation of the molecule, invented its use as PrEP, and funded four clinical trials to prove its efficacy?
Pressley challenges Gilead's pricing of PrEP, highlighting public funding of its development.
Share
More from Ayanna Pressley
This report makes plain the essential role that Haitian TPS holders play in our care economy and communities writ-large.
Every minute she remains in custody is another minute her health and rights are at risk.
This young girl, who we didn't know, 18 years old. I’m sure had her own plans and dreams that have all been cut short.
It is incumbent upon us all to treat mothers with the dignity, respect, and care that they deserve—and that means tackling the maternal morbidity crisis head on.
Other voices in this conversation
